The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 10, 2023

Filed:

May. 09, 2016
Applicant:

Rani Therapeutics, Llc, San Jose, CA (US);

Inventors:

Mir Imran, San Jose, CA (US);

Radhika Korupolu, San Jose, CA (US);

Elaine To, San Jose, CA (US);

Mir Hashim, San Jose, CA (US);

Assignee:

Rani Therapeutics, LLC, San Jose, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61M 25/10 (2013.01); A61K 38/28 (2006.01); A61K 38/26 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 39/00114 (2018.08); A61M 25/10 (2013.01); C07K 16/2866 (2013.01); A61K 2039/542 (2013.01); A61M 2025/105 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract

Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents within the GI tract such as neutralizing proteins (NP) particularly antibodies which neutralize interleukins. Many embodiments provide a swallowable device e.g., a capsule for delivering various agents into the intestinal wall (IW). Embodiments also provide agent preparations that are configured to be contained within the capsule, advanced from the capsule into the IW and degrade to release the agent into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW. Embodiments of the invention are particularly useful for the delivery of interleukin NP's (INP) for treatment of inflammatory conditions where such INP's are poorly absorbed, tolerated and/or degraded within the GI tract.


Find Patent Forward Citations

Loading…